Detalhe da pesquisa
1.
MIF/NR3C2 Axis Regulates Glucose Metabolism Reprogramming in Pancreatic Cancer through MAPK-ERK and AP-1 Pathways.
Carcinogenesis
; 2024 Apr 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38629149
2.
LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism.
Carcinogenesis
; 2024 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38366633
3.
ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer.
Int J Cancer
; 2024 Apr 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38630934
4.
Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients.
Carcinogenesis
; 43(12): 1198-1210, 2022 12 31.
Artigo
Inglês
| MEDLINE | ID: mdl-36426859
5.
NO⢠/RUNX3/kynurenine metabolic signaling enhances disease aggressiveness in pancreatic cancer.
Int J Cancer
; 146(11): 3160-3169, 2020 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31609478
6.
Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation.
J Biol Chem
; 287(21): 17109-17119, 2012 May 18.
Artigo
Inglês
| MEDLINE | ID: mdl-22451655
7.
SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer.
Cell Rep
; 42(12): 113434, 2023 12 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37980563
8.
Carnitine palmitoyltransferase 1C regulates cancer cell senescence through mitochondria-associated metabolic reprograming.
Cell Death Differ
; 25(4): 735-748, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29317762
9.
Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer.
Oncotarget
; 7(33): 52993-53004, 2016 Aug 16.
Artigo
Inglês
| MEDLINE | ID: mdl-27367029
10.
Endothelial Nitric Oxide Synthase Traffic Inducer (NOSTRIN) is a Negative Regulator of Disease Aggressiveness in Pancreatic Cancer.
Clin Cancer Res
; 22(24): 5992-6001, 2016 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27401251
11.
A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.
Cancer Res
; 76(13): 3838-50, 2016 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27197190
12.
Reversal effect of Tween-20 on multidrug resistance in tumor cells in vitro.
Biomed Pharmacother
; 66(3): 187-94, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22440896